Objective: The aim of this study is to determine the CRP as a prognostic indicator in hospitalized patients with COVID-19. Study Design: Retrospective observational study Place and Duration: Sahiwal Medical College, Sahiwal. Jan 2021-Nov 2021 Methods: There were ninety patients had coronavirus disease of both genders were presented in this study. Patients were aged between 20-75 years were admitted in hospital. Informed written consent was taken from all the patients for detailed demographics age, sex, body mass index, education status and residency. Symptoms and comorbidities were calculated among all patients. Outcomes were CRP level was indicated among severe, non-severe and died patients with pandemic disease. Hospital stay was also calculated. Chi square and test was used for categorical variables. SPSS 22.0 version was used to analyze complete data. Results: Mean age of the patients was 50.12±3.45 years with mean BMI 27.88±6.34 kg/m2. Majority of the patients 55 (61.1%) were males and 35 (38.9%) were females. 52 (57.8%) cases were from urban areas and 38 (42.2%) were from rural areas. 49 (54.4%) patients were literate. Fever, dry cough and fatigue were the most common symptoms in patients. Hypertension and diabetes mellitus were the most common comorbidity. Among 90 cases, rate of mortality was 19 (21.1%). We found that mean CRP level among died patients were significantly higher 184.11±89.67 mg/L as compared to severe patients 134.13±111.14 mg/L and non-severe patients 89.34±64.43 mg/L. Mean hospital stay was 6.09±6.34 days. Conclusion: According to our findings, CRP levels rise rapidly in COVID-19 patients, and these data suggest that CRP could be used clinically to predict COVID-19 prognosis and severity before disease progression and the manifestation of clinical symptoms. CRP is an acute-phase, non-specific serological biomarker of inflammation and infection and is linked to disease severity and outcomes.